Ann: Admedus Strengthens Management Team-AHZ.AX, page-83

Following the incumbent payout of 0,5mill dollars for managing a FY 25mill loss.
Reviewing current performance with residing chair
Closing SP on 30^th June 2016 : 0.33 Cents
Closing SP on 30^th Sept 2016: 0.32 Cents
WP has increased shareholder value by – 3.2% in his first quarter


My opinion:
A CEO is judged ultimately by performance of share price(however great one appears). The prognosis is not great today but probably to be fair judge and jury a couple more quarters required but saying he was on board since late 2014 so complicit to some degree where the company is today . Is there a new payrise now in the offering?
I have my concerns as previously posted on our profitability that is way way to optimistic. One of my big ones is Vascucel launch next quarter. this really is commercial suicide where global price from biggest competitor and market is between 100-200 us dollars. I cannot see how this will ever be profitable. This is an announcement to me more appease investors that we are launching new products, etc, etc and how great we are to do this. enough ranting from me on these boards off to enjoy the weekend. look forward to seeing the big rocket ship if we see a couple of extra cents increase next week otherwise it will big subs lurking!